SymKardia

Manufacturing · 11-50 Employees

View Company Info for Free

Overview

Revenue

<$5 Million

Industry

Manufacturing Medical Devices & Equipment
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About SymKardia

SymKardia, Inc. is a U.S.-based medical device company focused on transforming the treatment of cardiac arrhythmias through a novel approach called cardiac neuromodulation. Unlike conventional therapies that act directly on heart tissue, SymKardia is developing technologies that target the nervous system pathways controlling the heart, aiming to deliver more precise and effective rhythm management.Explore more
Popular SearchesSymKardiaSIC Code 38,384NAICS Code 33,339Show more

SymKardia Org Chart

Bruce KenKnight, Chief Executive Officer at SymKardia

Chief Executive Officer

PhoneEmail
Dwight Skinner, Chief Operating Officer at SymKardia

Chief Operating Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is SymKardia your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

SymKardia financials insights

Gather financial insights about SymKardia, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2026

Debt

$500K

See All SymKardia's Financials Insights

Top Manufacturing Companies

Frequently Asked Questions Regarding SymKardia

What is SymKardia's official website?
SymKardia's official website is www.symkardia.com
What is SymKardia's Revenue?
SymKardia's revenue is <$5 Million
What is SymKardia's SIC code?
SymKardia's SIC: 38,384
What is SymKardia's NAICS code?
SymKardia's NAICS: 33,339
How many employees does SymKardia have?
SymKardia has 11-50 employees
What industry does SymKardia belong to?
SymKardia is in the industry of: Manufacturing, Medical Devices & Equipment
What does SymKardia do?

SymKardia, Inc. is a U.S.-based medical device company focused on transforming the treatment of cardiac arrhythmias through a novel approach called cardiac neuromodulation. Unlike conventional therapies that act directly on heart tissue, SymKardia is developing technologies that target the nervous system pathways controlling the heart, aiming to d... eliver more precise and effective rhythm management.Read More

Is SymKardia a public company?
SymKardia is private company therefore does not currently have an official ticker symbol
See more information about SymKardia

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.